AtriCure, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery
AtriCure, Inc. (ATRC) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-02-19
- AtriCure, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2025 was $0.00.
- AtriCure, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2024 was $0.00.
- AtriCure, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- AtriCure, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2022 was $1.06M, a 1524.62% increase from fiscal 2021.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-19 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-19 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-19 |
| 2022-12-31 | $1.06M 10-K · filed 2025-02-14 |
| 2021-12-31 | $65.00K 10-K · filed 2024-02-16 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |